The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

FDA Commissioner Marty Makary hinted on Sunday at shifting the U.S. healthcare system away from standard treatment to a more ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Commissioner Marty Makary argued that insulin should be withheld from people with diabetes and replaced with "cooking classes ...

People with type 1 diabetes require insulin to live, while those with type 2 diabetes use insulin and other medications to ...

Ozempic is an injectable semaglutide medication approved by the Food and Drug Administration (FDA) to help manage type 2 diabetes and assist in blood sugar management, alongside lifestyle changes.

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

The crackdown on off-brand weight loss drugs and diabetes treatments are about to take effect, meaning supplies or treatments are likely to tighten up as well.

Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what ...